Low global SARS-CoV-2 circulation and the absence of any novel coronavirus with pandemic potential underpin the 95.2% market-implied odds against a new 2026 coronavirus pandemic. Official surveillance through mid-2026 shows declining cases, test positivity rates near 1-2%, and variants under monitoring such as BA.3.2 exhibiting immune escape but limited dominance or severity increases. Widespread population immunity from prior infection and vaccination, combined with no WHO-declared Public Health Emergency of International Concern, reinforces trader consensus. Realistic shifts could occur if a highly divergent strain emerges with enhanced transmissibility and virulence, or if zoonotic spillover produces a new coronavirus capable of sustained human-to-human spread, prompting updated genomic and epidemiological monitoring.